Despite having an estimated two times higher risk of death than white Americans from the COVID-19 pandemic, Indigenous people in the U.S. and Canada experienced surprisingly positive outcomes––they exhibited an impressive ...
Jul 19, 2023
0
6
A multidisciplinary group of tuberculosis experts from the TBnet and RESIST-TB networks have reached a consensus on key issues related to the molecular prediction of Mycobacterium tuberculosis antibiotic sensitivity or resistance ...
Apr 14, 2023
0
9
Since September, 2022, bivalent mRNA vaccines—which contain elements from both the original wild type COVID strain and an updated component from the omicron strain—have replaced older style monovalent boosters in the ...
Apr 13, 2023
0
39
Scientists from the University of Oxford, working as part of the EBOVAC2 EBL2001 study group, have today announced the results of a phase 2 trial of a replication-deficient adenovirus vaccine aimed at providing protection ...
Nov 18, 2020
0
8
Col. (Dr.) Michael Xydakis, an ear, nose and throat surgeon in the Air Force Research Laboratory, assembled a multi-national team of nine other medical professionals, who consolidated their front-line observations and recommendations ...
Apr 16, 2020
0
2
A new study from ICES, Lawson Health Research Institute and Western University suggests that injection drug users prescribed controlled-release hydromorphone are three times more likely to develop endocarditis, a serious ...
Jan 22, 2020
0
1
The Lancet Infectious Diseases recently published the results of an observational study led by researchers on Children's Hospital Colorado Infectious Disease and Neurology teams, along with counterparts at the Centers for ...
Jan 8, 2020
0
3
Bloodstream infections caused by the fungus Candida are among the most common and deadly infections in hospitals, with 25,000 such cases seen annually in the U.S. - mostly in people originally hospitalized for other reasons. ...
Sep 25, 2019
0
6
A Middle East respiratory syndrome coronavirus (MERS CoV) vaccine candidate was shown to be safe, well-tolerated, and induced a robust immune response in a Phase 1 first-in-human clinical trial. Initial findings from the ...
Jul 25, 2019
0
3
In 2016, there were 87 million people diagnosed with gonorrhoea, the most antibiotic resistant of all the STIs. There is a global rise in gonorrhoea rates and, until now, no one has understood why.
Jul 17, 2019
0
16
